President John Mahama has appointed Professor Kwabena Frimpong-Manso Opuni as the acting Chief Executive Officer (CEO) of the Food and Drugs Authority (FDA).
The appointment, which takes effect on Monday, July 14, 2025, was announced in a Facebook post by the FDA.
According to the Authority, Prof. Opuni previously served as Chairman of the FDA Board and brings extensive experience in public health regulation and governance to the role.
He succeeds Dr. Delese Mimi Darko, who served as CEO from 2017 until her recent elevation to the role of Director-General at the Africa Medicines Agency (AMA).
The FDA commended Dr. Darko for her years of dedicated service, during which the Authority recorded significant progress in regulatory oversight, public safety, and international collaboration.
Her new appointment at the AMA has been widely praised as a testament to her impactful leadership in the health regulatory space.
The Authority congratulated Prof. Opuni on his appointment and expressed confidence in his ability to advance the FDA’s mission of protecting public health and ensuring the safety, quality, and efficacy of regulated products across Ghana.
Source: Adomonline.com
ALSO READ:
